This year, ANIO is pleases to announce academic excellence award to Dr. Chirag Parikh. Dr. Parikh is a Professor of Medicine and the Division Director of Nephrology at Johns Hopkins University. He received his medical degree from Seth G.S. Medical College and KEM Hospital in Mumbai, India and subsequently completed his Nephrology fellowship and a PhD in Clinical Investigation at the University of Colorado Health Sciences Center.
Dr. Parikh’s research focuses on the translation and validation of novel biomarkers for the diagnosis and prognosis of acute kidney injury. Progress in kidney diseases has been hamstrung by significant heterogeneity within the current disease definitions, which are largely based on serum creatinine. Dr. Parikh’s research has addressed this critical challenge by developing biomarkers of renal tubular injury, repair, and inflammation to dissect this heterogeneity. He has assembled multicenter longitudinal prospective cohorts for translational research studies across several clinical settings of acute kidney injury and chronic kidney disease for the efficient translation of novel biomarkers. Dr. Parikh’s research goal is to translate our understanding of pathophysiological mechanisms into clinical practice and to improve outcomes in patients with kidney disease.
Dr. Parikh has been the recipient of numerous honors and awards, including the 2017 Young Investigator Award from the American Society of Nephrology. He also was elected to the prestigious American Society of Clinical Investigation in 2018.
Please join us in congratulating Dr. Parikh on this award!
ANIO is pleased to announce this year’s academic excellence award to Dr. Ananth Karumanchi. Dr. Ananth Karumanchi is currently the Director of Renovascular Research and Medallion Chair in Vascular Biology in the Department of Medicine at the Cedars-Sinai Medical Center, Los Angeles. Dr. Karumanchi also has a secondary appointment as Professor of Medicine at Harvard Medical School, Boston and Staff Scientist in Renal Division at the Beth Israel Deaconess Medical Center (BIDMC). Dr. Karumanchi completed his medical degree from Kilpauk Medical College, University of Madras, India (1992). He then completed his residency in Internal Medicine at the Henry Ford Hospital, Detroit (1996) and fellowship in Nephrology at BIDMC, Boston (1999). Dr. Karumanchi also underwent training in basic research in the area of tumor suppressors and angiogenesis for 4 years at Harvard Medical School, Boston. He initiated his independent research laboratory in 2000 and has focused on discovering pathogenic pathways and bringing therapies to patients in the areas of hypertensive disorders of pregnancy and chronic kidney diseases. Dr. Karumanchi’s research activities are vertically integrated, ranging from molecular and cell biological studies to animal models to first-in-class human clinical trials. Dr. Karumanchi has published nearly 300 papers (with several publications in NEJM, Circulation, Nature, Nature Medicine, JCI, Hypertension; H index = 85) and 25 book chapters. He has received prestigious awards from several societies including recognitions from American Heart Association (AHA) – Established Investigator Award (2008), the International Society for the Study of Hypertension in Pregnancy – Chesley Award (2010) – and Outstanding Investigator Award from the American Federation for Medical Research (2010). He was also elected as a member of the American Society for Clinical Investigation (ASCI) in 2007 and Association of American Physicians (AAP) in 2015. Dr. Karumanchi’s research has been funded by the NIH, AHA, Howard Hughes Medical Institute and the Gates Foundation.
